Oral Epigallocatechin Gallate Reduces Intestinal Nadolol Absorption via Modulation of Oatp1a5 and Oct1 Transcriptional Levels in Spontaneously Hypertensive Rats
Publication date: Available online 11 June 2021Source: PhytomedicineAuthor(s): Hong-Jie Tan, Wei-Chih Ling, Ang-Lim Chua, Siew-Keah Lee (Source: Phytomedicine)
Source: Phytomedicine - June 12, 2021 Category: Drugs & Pharmacology Source Type: research
Dose response to nadolol in congenital Long QT Syndrome.
Betablocker therapy is the corner stone to treat long QT syndrome patients (LQTS). Few details are given on the dose to be used. As the response is variable between patients, we systematically evaluated effect of treatment by performing an exercise test. (Source: Heart Rhythm)
Source: Heart Rhythm - April 24, 2021 Category: Cardiology Authors: Soraya Anys, Marine Arnaud, Damien Minois, Annabelle Rajalu, B éatrice Guyomarch, Aurélie Thollet, Jean-Baptiste Gourraud, Vincent Probst Source Type: research
Dose response to nadolol in congenital long QT syndrome
Beta-blocker therapy is the cornerstone of treatment for patients with long QT syndrome (LQTS). Few details on the dose to be used are available. As the response is variable between patients, we systematically evaluated the effect of treatment by performing an exercise test. (Source: Heart Rhythm)
Source: Heart Rhythm - April 24, 2021 Category: Cardiology Authors: Soraya Anys, Marine Arnaud, Damien Minois, Annabelle Rajalu, B éatrice Guyomarch, Aurélie Thollet, Jean-Baptiste Gourraud, Vincent Probst Source Type: research
Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):687-695. doi: 10.47162/RJME.61.3.07.ABSTRACTInfantile hemangiomas (IHs) are the most frequent pediatric benign vascular tumors, with a reported incidence of 5% to 10%. They have self-limiting evolution pattern divided into a growth phase in the first 12 months and a regression one, that may take up to 10 years. Occasionally, hemangiomas might lead to local or systemic complications, depending on their morphological characteristics. The first line of treatment is β-blockers, such as Propranolol, Timolol, Nadolol, administered either locally or systemically. Newer therapeutic strate...
Source: Romanian Journal of Morphology and Embryology - April 5, 2021 Category: General Medicine Authors: Alina Costina Luca Ingrith Crengu ţa Miron Laura Mihaela Trandafir Elena Cojocaru Ioana Alexandra P ădureţ Mioara Florentina Trandafirescu Alin Constantin Iordache Elena Ţarcă Source Type: research
